דלג לתוכן הראשי
Brain

Scientists Discover Surprising Similarity Between Brain Aging in Mice and Humans

For decades, aging research has relied on mice as a model for humans—but always with a caveat: who says a mouse brain ages like a human one? A new study published in the prestigious journal Nature Aging uses single-cell sequencing to answer this question for the first time—and the answer is surprising: <strong>the similarity is deeper than we thought</strong>, which strengthens the credibility of mouse-based aging research.

📅02/05/2026 ⏱️4 דקות קריאה ✍️Reverse Aging 👁️36 צפיות

If you ask an anti-aging researcher what the biggest criticism of their field is, the standard answer would be: "Most research is done on mice, and mice are not humans". Rapamycin extended mouse lifespan by 25%. Dasatinib + Quercetin cleared zombie stem cells in mice and restored their agility. But every such success is always questioned in the final paragraph: "Will it work in people?"

A new study published this week in Nature Aging provides the first answer at the single-cell level. The researchers compared RNA sequencing of 1.6 million brain cells—half from mice of different ages, half from humans—and found a deeper similarity than previously thought.

The Technology: Single-Cell Sequencing (scRNA-seq)

Until a decade ago, if you wanted to know which genes brain tissue expresses, you would grind up the entire tissue and perform average sequencing. The problem: the brain is a gallery of different cells—neurons, microglia, astrocytes, oligodendrocytes, blood cells—and each "speaks" a different genetic language. Their average is noise.

Single-cell RNA sequencing technology changes all that. Each cell is individually isolated, its RNA is sequenced, and you can see which genes are expressed in each cell separately. Now the team performed the same process on mice aged 3 months to 24 months, and on humans aged 20 to 95.

4 Identical Aging Signatures

The main finding: Even though mice live ~2 years and humans ~80 years, the aging pathways in the main cells are strikingly identical. The researchers found 4 "signatures" present in both species:

1. Inflammatory Microglial Activation

Microglia are the brain's immune cells. In youth, they are "quiet"—scanning the environment and responding only when there is a threat. With age, they become chronically activated, secreting inflammatory cytokines (TNF-α, IL-6, IL-1β). The exact same pattern was observed in old mice and old humans.

2. Myelin Loss in Oligodendrocytes

Myelin is the insulation of nerve fibers. Its loss slows brain communication. In both species, old oligodendrocytes express fewer genes for MBP, MOG, and PLP1—the main components of myelin. In mice, this occurs from 18 months; in humans, from age 50.

3. Decline in Neuronal Synapses

Old neurons downregulate genes related to synaptic function—SYP, SYN1, PSD95. This explains the decline in learning and memory speed with age. Again, the same pattern in both species.

4. Metabolic Disruption in Astrocytes

Astrocytes are responsible for supplying glucose to neurons. In old age, they become less efficient at this—genes related to metabolism and lactate transport decrease in expression. This contributes to cognitive slowing.

What Is Different?

Despite the similarity, the researchers identified several important differences:

  • Pace: Mice undergo the same changes about 30 times faster. One year in a mouse ≈ 30 years in us, roughly.
  • Neurogenesis: Mice retain more ability to generate new neurons in old age; humans have largely lost this ability.
  • Neural Stem Cells: Preserved in mice, almost completely absent in humans.
  • Specific Brain Pathologies: Alzheimer's and Parkinson's appear in mice only in genetically engineered models, not spontaneously.

Why This Matters for Anti-Aging Research

The implications of the finding are broad:

Strengthening Translation from Lab to Clinic

If the 4 main aging signatures are identical in both species, then a treatment that addresses them in mice is more likely to work in us. Rapamycin, senolytics, NAD+—all act on these pathways. This is not a guarantee, but it is a tailwind for clinical efforts.

New Directions for Treatment

The findings point to preferred therapeutic targets:

  • Calming inflammatory microglia (senology in the brain).
  • Restoring myelin (anti-old-oligodendrocyte treatments).
  • Improving astrocyte metabolism.
  • Supporting synaptic function.

Better Models

The researchers suggest that accelerated-aging mice (like SAMP mice) reflect human aging better than regular wild-type mice, and this is an important direction for future studies.

The Bottom Line

For years, skeptics said: "How can you study human brain aging from a mouse?". This team gave a numerical answer: 1.6 million cells confirm that the main aging pathways are identical. This does not mean everything that works in mice will work in people. But it leaves us with far fewer reasons to worry when seeing successful lab results.

References:
News-Medical: Brain Aging Research
Nature Aging

מקורות וציטוטים

💬 תגובות (0)

תגובות אנונימיות מוצגות לאחר אישור.

היו הראשונים להגיב על המאמר.